Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO




Papadopoulos, Nikolaos G.; Custovic, Adnan; Deschildre, Antoine; Gern, James E.; Nieto Garcia, Antonio; Miligkos, Michael; Phipatanakul, Wanda; Wong, Gary; Xepapadaki, Paraskevi; Agache, Ioana; Arasi, Stefania; El-Sayed, Zeinab Awad; Bacharier, Leonard B.; Bonini, Matteo; Braido, Fulvio; Caimmi, Davide; Castro-Rodriguez, Jose A.; Chen, Zhimin; Clausen, Michael; Craig, Timothy; Diamant, Zuzana; Ducharme, Francine M.; Ebisawa, Motohiro; Eigenmann, Philippe; Feleszko, Wojciech; Fierro, Vincezo; Fiocchi, Alessandro; Garcia-Marcos, Luis; Goh, Anne; Gomez, Rene Maximiliano; Gotua, Maia; Hamelmann, Eckard; Hedlin, Gunilla; Hossny, Elham M.; Ispayeva, Zhanat; Jackson, Daniel J.; Jartti, Tuomas; Jesenak, Milos; Kalayci, Omer; Kaplan, Alan; Konradsen, Jon R.; Kuna, Piotr; Lau, Susanne; Le Souef, Peter; Lemanske, Robert F.; Levin, Michael; Makela, Mika J.; Mathioudakis, Alexander G.; Mazulov, Oleksandr; Morais-Almeida, Mario; Murray, Clare; Nagaraju, Karthik; Novak, Zoltan; Pawankar, Ruby; Pijnenburg, Marielle W.; Pite, Helena; Pitrez, Paulo M.; Pohunek, Petr; Price, David; Priftanji, Alfred; Ramiconi, Valeria; Rivero Yeverino, Daniela; Roberts, Graham; Sheikh, Aziz; Shen, Kun-Ling; Szepfalusi, Zsolt; Tsiligianni, Ioanna; Turkalj, Mirjana; Turner, Steve; Umanets, Tetiana; Valiulis, Arunas; Vijveberg, Susanne; Wang, Jiu-Yao; Winders, Tonya; Yon, Dong Keon; Yusuf, Osman M.; Zar, Heather J.

2024

Pediatric Allergy and Immunology

PEDIATRIC ALLERGY AND IMMUNOLOGY

e14129

35

4

0905-6157

1399-3038

DOIhttps://doi.org/10.1111/pai.14129

https://doi.org/10.1111/pai.14129

https://research.utu.fi/converis/portal/detail/Publication/393539164



Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even "real-time," monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design. 


This study was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis, and Sanofi for continued work on PeARL.


Last updated on 2024-28-11 at 12:18